Arrow-right Camera
Subscribe now

DNA war continues

The unanimous June 13 decision by the U.S. Supreme Court is a big deal. The court struck down “naturally occurring DNA” as unpatentable, but left open the possibility of “synthetically created” DNA as patentable subject matter. But the fight against corporations owning DNA rights is not over. Although protesters have lowered their signs, some may have missed the mark.

Myriad Genetics owns “process patents” detailing specific processes for testing patients’ genes for cancer susceptibility. Undoubtedly, many similar patents will come from Myriad and its competitors. The court decided whether the DNA itself could be patented, but solidified the concept that the methods for testing and analyzing DNA, as well as the creation of certain strands of cDNA (synthetic DNA), are patentable.

What result? Myriad and its competitors can still own the rights to exclude others from utilizing certain DNA testing methods. The effect of the court’s ruling, which largely underscored the eligibility of method claims surrounding DNA, as well as utility claims surrounding cDNA, is not completely redeeming.

Although the court finally determined that manipulated DNA is unpatentable, the court’s decision begs the question whether the government should protect intellectual property rights for methods of testing human DNA. The war is not yet won.

Geoffrey Palachuk

Spokane Valley



Letters policy

The Spokesman-Review invites original letters on local topics of public interest. Your letter must adhere to the following rules:

  • No more than 250 words
  • We reserve the right to reject letters that are not factually correct, racist or are written with malice.
  • We cannot accept more than one letter a month from the same writer.
  • With each letter, include your daytime phone number and street address.
  • The Spokesman-Review retains the nonexclusive right to archive and re-publish any material submitted for publication.

Unfortunately, we don’t have space to publish all letters received, nor are we able to acknowledge their receipt. (Learn more.)

Submit letters using any of the following:

Our online form
Submit your letter here
Mail
Letters to the Editor
The Spokesman-Review
999 W. Riverside Ave.
Spokane, WA 99201
Fax
(509) 459-3815

Read more about how we crafted our Letters to the Editor policy